News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
Presentation EuroPCR 2018 Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2) Presenter: Panagiotis Xaplanteris May 23, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News EuroPCR 2016 Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease Caitlin E. Cox May 19, 2016
News Conference News EuroPCR 2015 DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk Yael L. Maxwell May 19, 2015
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News EuroPCR 2012 FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy Caitlin E. Cox May 15, 2012
News Conference News EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out May 23, 2011